The global medical simulation market size was estimated at USD 2.18 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 16.7% from 2023 to 2030. Growing technological advancements, preference for minimally invasive treatment, and focus on patient safety are the factors anticipated to boost the market growth. The COVID-19 pandemic has negatively impacted various market players. Canadian Aviation Electronics, Ltd reported that medical and nursing schools are a major part of the simulation products market. This has negatively impacted their ability in completing contracts and also in delivering existing orders.
COVID-19 began to hamper the demand in Asia early in the fourth quarter of the financial year 2020, with border restrictions in place, and in North America and Europe, later in March. Within the hospital market, customers were predominantly focused on handling acute operational demands due to the ongoing healthcare crisis instead of focusing on their training needs. This could result in less focus and budget for normal operations and training projects in the near term. Manufacturing operations for healthcare products also continued during the pandemic. Such a pattern of demand was observed in other companies as well.
Medical simulation in healthcare creates a safe learning environment, within which practitioners and researchers can test new clinical processes and enhance their teams’ and individuals’ skills. Most of the simulation applications include artificial patients, who can display symptoms and also respond to the simulated treatment. This allows specialists to enhance their clinical skills without risking patient lives.
Pandemic Impact |
Post-COVID-19 Outlook |
The market experienced a growth rate of 1.5% from 2019 to 2020, as compared to 9.2% as per the earlier projections. |
Post-COVID-19, with the easing lockdowns, the market is expected to gain pace in 2021, by reaching USD 1.90 Billion. |
Canadian Aviation Electronics, Ltd experienced delays in delivering existing orders due to COVID-19, which impacted its revenue growth as well. |
The market players are also expected to invest in launching new products and other strategies, to recover from the COVID-19 impact. |
Companies are involved in launching technologically advanced solutions in the market, which is also boosting the market growth. For instance, in January 2020, CAE Healthcare released the CAE Vimedix 3.0 ultrasound simulator that provides VR as well as 3D/4D ultrasound images of the heart. Furthermore, in January 2018, Gaumard Scientific Company launched the Pediatric HAL S2225, which is advanced wireless and tetherless mobile pediatric patient simulator. These factors are expected to positively impact market growth.
Based on products and services, the market is segmented into web-based simulators, healthcare anatomical models, simulation training services, and healthcare simulation software. The Healthcare anatomical models segment is further classified into task trainers, patient simulators, interventional/surgical simulators, ultrasound simulators, dental simulators, endovascular simulators, and eye simulators.
The healthcare anatomical model segment held the largest market share of more than 30.47% in 2020. These simulators are proving to be beneficial in the research and manufacturing industry for conducting trials and permutations and combinations before finalizing design, processes, or systems, especially in the medical devices industry. These factors are anticipated to contribute to the growth of the segment over the forecast period.
Based on technology, the medical simulation market is segmented into virtual patient simulation, 3D printing, and procedural rehearsal technology. The procedure rehearsal technology segment held the largest share of 38.9% in 2022. The rising number of medical errors leading to increasing demand for patient safety is expected to boost the demand for procedure rehearsal technology. Market players are involved in technological advancements, which is expected to fuel market growth.
The virtual patient simulation segment is expected to expand at a lucrative CAGR of over 18.9% during the forecast period. The technology has many applications in medical school curricula. Companies dealing in virtual patient simulation include 3D Systems, Simulab Corporation, Simulaids, and Surgical Science Sweden AB.
Based on the end-use, the market is classified into military organizations, academic institutes, research, and hospitals. The academic institutes' segment held the largest share of 30.67% in 2020. The academic research institutions segment is likely to witness persistent growth due to the presence of several academic research groups that are involved in the study of complex biological systems using computer models. For instance, the NIDDK studied the outcome of decreased kidney function on pharmacokinetics by drugs expelled renally by organic anion transporters through PBPK modeling.
The hospitals segment is expected to witness the fastest growth rate of around 16.6% during the forecast period owing to a gradual shift of focus on advanced learning, the advent of advanced simulation-based technologies, full utilization of simulation models in medical surgeries, increasing focus on minimizing errors, and cost-effectiveness of procedural training for medical physicians.
In 2022, North America held the largest revenue share of 46.90%. The market growth can be attributed to various factors such as the presence of key players in the region and high investments in the technology. Moreover, rapid technological advancements and high disposable income are some of the factors expected to fuel the market growth over the forecast period.
The Asia Pacific segment is anticipated to witness significant growth over the forecast period owing to the constant improvements in healthcare infrastructure. Moreover, the rising adoption of healthcare facilities coupled with the rapid expansion of manufacturing facilities in emerging countries, such as China and India, is propelling the market growth.
Vendors are investing in product launches, geographical expansions, collaborative agreements, and acquisitions, to sustain in the market. The market is expected to become highly competitive as many startups are seeking opportunities in this sector. For instance, in December 2020, CAE received ISO 13485:2016 certification for its facilities in Montreal (Canada) and Sarasota (U.S.). Both are medical device and quality management systems facilities. Also, in August 2020, TruCorp and Laerdal Medical partnered to bring a cost-effective & easy-to-implement ventilation training solution to the market. Some of the prominent players operating in the global medical simulation market are:
CAE (Canadian Aviation Electronics, Ltd)
Laerdal Medical
3D Systems
Simulab Corporation
Limbs & Things Ltd
Simulaids
Kyoto Kagaku Co., Ltd
Gaumard Scientific Company
Mentice AB
Surgical Science Sweden AB
Report Attribute |
Details |
Market size value in 2023 |
USD 2.5 billion |
Revenue forecast in 2028 |
USD 7.49 billion |
Growth Rate |
CAGR of 16.7% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD Million & CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered |
Products & services, technology, end use, region |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S., Canada, Germany, UK, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, Australia, India, Thailand, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
Key companies profiled |
CAE; Laerdal Medical; 3D Systems; Simulab Corporation; Limbs & Things Ltd; Mentice AB; Simulaids; Gaumard Scientific Company; Surgical Science Sweden AB; Kyoto Kagaku Co., Ltd |
Customization scope |
Free report customization (equivalent to up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail of customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global medical simulation market report based on product and services, technology, end use, and region:
Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
Healthcare Anatomical Models
Patient Simulators
Task Trainers
Interventional/Surgical Simulators
Laparoscopic Surgical Simulators
Gynecology Simulators
Cardiovascular Simulators
Arthroscopic Surgical Simulators
Spine Surgical Simulators
Other Interventional/Surgical Simulators
Endovascular Simulators
Ultrasound Simulators
Dental Simulators
Eye Simulators
Web-Based Simulators
Healthcare Simulation Software
Simulation Training Services
Technology Outlook (Revenue, USD Million, 2018 - 2030)
Virtual Patient Simulation
3D Printing
Procedure Rehearsal Technology
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Academic Institutes
Hospitals
Military Organizations
Research
Medical Device Companies
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global medical simulation market size was estimated at USD 2.18 billion in 2022 and is expected to reach USD 2.5 billion in 2023.
b. The global medical simulation market is expected to grow at a compound annual growth rate of 16.7% from 2023 to 2030 to reach USD 7.49 billion by 2030.
b. North America dominated the medical simulation market with a share of 46.49% in 2022. This is attributable to rising medical training institutes and hospitals, which are mainly focusing on standardizing their teaching practices to enhance patient safety.
b. Some key players operating in the medical simulation market include Canadian Aviation Electronics, Ltd.; Laerdal Medical AS; Kyoto Kagaku Co, Ltd., Limbs & Things, Ltd.; Mentice AB; Simulab Corporation; Simulaids, Inc.; Gaumard Scientific Company, Inc.; 3D Systems, Inc.; and Surgical Science Sweden AB.
b. Key factors that are driving the medical simulation market growth include growing technological advancements, rising demand for minimally invasive procedures, and increasing focus on patient safety.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."